HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minoxidil 5%

This article was originally published in The Rose Sheet

Executive Summary

Alpharma began shipping generic version of hair regrowth treatment Nov. 18 following debut at Private Label Manufacturers Association trade show in Chicago Nov. 13-14. The 60 mL bottles will be sold in single-, double- and triple-packs and will retail for $14.99-$19.99 per bottle, the company says. ANDAs for the topical solution submitted by Alpharma (75-518) and Copley (75-619) cleared FDA on Nov. 17; Pharmacia's Rogaine Extra Strength for Men lost exclusivity Nov. 14. Perrigo also plans to offer generic version of minoxidil 5%, but was forced to delay shipping until April due to an unfavorable FDA inspection of its Allegan, Mich. facility (1"The Rose Sheet" Nov. 6, In Brief)

You may also be interested in...



Minoxidil delay

Perrigo's private-label minoxidil 5% November launch precluded due to corrective actions taken in response to unfavorable FDA inspection of Perrigo's Allegan, Mich. facility, firm says. Perrigo had hoped to introduce minoxidil 5% immediately following the Nov. 14 expiration of Pharmacia's exclusivity for Rogaine Extra Strength; Copley Pharmaceutical and Alpharma already have received tentative approvals (1"The Rose Sheet" Feb. 7, In Brief). Perrigo expects its global action plan to reform the plant's quality control system and enable full resumption by FY 2002 (begins July 1). FDA's Detroit district investigators uncovered cGMP violations during mid-year inspection

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel